167 related articles for article (PubMed ID: 33689917)
1. Expectant management of retained products of conception following abortion: A retrospective cohort study.
Wada Y; Takahashi H; Suzuki H; Ohashi M; Ogoyama M; Nagayama S; Baba Y; Usui R; Suzuki T; Ohkuchi A; Fujiwara H
Eur J Obstet Gynecol Reprod Biol; 2021 May; 260():1-5. PubMed ID: 33689917
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Reproductive Outcomes following Retained Products of Conception after Vaginal Delivery versus First-Trimester Abortion.
Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I
Gynecol Obstet Invest; 2015; 80(3):206-10. PubMed ID: 26088169
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive pills as an option for non-surgical management of retained products of conception - a preliminary study.
Hershko Klement A; Frederic M; Bentov Y; Chang P; Nayot D; Haas J; Casper RF
Gynecol Endocrinol; 2018 Jul; 34(7):609-611. PubMed ID: 29345165
[TBL] [Abstract][Full Text] [Related]
4. [Expectant therapy versus curettage for retained products of conception after second trimester termination of pregnancy: analysis of outcomes and complications].
Zeng WJ; An SL; Huang H; Huang QT; Li FF; Wang HZ; Cai DC; Gao YF
Nan Fang Yi Ke Da Xue Xue Bao; 2017 May; 37(5):569-574. PubMed ID: 28539276
[TBL] [Abstract][Full Text] [Related]
5. Conservative management for retained products of conception after less than 22 weeks of gestation.
Shitanaka S; Chigusa Y; Kawahara S; Kawasaki K; Mogami H; Mandai M; Kondoh E
J Obstet Gynaecol Res; 2020 Oct; 46(10):1982-1987. PubMed ID: 32761752
[TBL] [Abstract][Full Text] [Related]
6. Natural history of pregnancy-related enhanced myometrial vascularity following miscarriage.
Grewal K; Al-Memar M; Fourie H; Stalder C; Timmerman D; Bourne T
Ultrasound Obstet Gynecol; 2020 May; 55(5):676-682. PubMed ID: 31503383
[TBL] [Abstract][Full Text] [Related]
7. Conservative management of retained products of conception in the normal placental position: A retrospective observational study.
Takahashi H; Ohhashi M; Baba Y; Nagayama S; Ogoyama M; Horie K; Suzuki H; Usui R; Ohkuchi A; Matsubara S
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():87-92. PubMed ID: 31238204
[TBL] [Abstract][Full Text] [Related]
8. Does the time interval between the diagnosis to hysteroscopic evacuation of retained products of conception affect reproductive outcome?
Tarasov M; Burke YZ; Stockheim D; Orvieto R; Cohen SB
Arch Gynecol Obstet; 2020 Dec; 302(6):1523-1528. PubMed ID: 32785781
[TBL] [Abstract][Full Text] [Related]
9. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic vascularity assessment for predicting future severe hemorrhage in retained products of conception after second-trimester abortion.
Akiba N; Iriyama T; Nakayama T; Seyama T; Sayama S; Kumasawa K; Komatsu A; Yabe S; Nagamatsu T; Osuga Y; Fujii T
J Matern Fetal Neonatal Med; 2021 Feb; 34(4):562-568. PubMed ID: 31006292
[No Abstract] [Full Text] [Related]
11. The RPOC long axis is a simple indicator for predicting the need of invasive strategies for secondary postpartum hemorrhage in either post-abortion or post-partum women: a retrospective case control study.
Kobayashi M; Nakagawa S; Kawanishi Y; Masuda T; Maenaka T; Toda A; Miyake T; Hiramatsu K; Miyoshi A; Mimura K; Kimura T; Endo M; Kimura T
BMC Pregnancy Childbirth; 2021 Sep; 21(1):653. PubMed ID: 34560846
[TBL] [Abstract][Full Text] [Related]
12. Hysteroscopic Removal of Retained Products of Conception Implanted Over a Focal Area of Adenomyosis: A Case Report.
Alonso L; Nieto L; Carugno J
J Minim Invasive Gynecol; 2018; 25(3):382-383. PubMed ID: 28939480
[TBL] [Abstract][Full Text] [Related]
13. Sonographic Findings of Vascular Signals for Retained Products of Conception in Women Following First-Trimester Termination of Pregnancy.
Lin F; Chen Z; Tao H; Ren X; Ma P; Lash GE; Shuai H; Li P
J Obstet Gynaecol Can; 2024 Mar; 46(3):102266. PubMed ID: 37940040
[TBL] [Abstract][Full Text] [Related]
14. Retained products of conception (RPOC) following delivery without placenta previa: Which patients with RPOC show postpartum hemorrhage?
Takahashi H; Tanaka H; Osuga Y; Miura K; Saito S; Sato S; Sugawara J; Ide S; Koh I; Yamauchi K; Okuyama A; Okuno K; Kuwata T; Fujieda S; Ikeda T
Placenta; 2022 Jun; 124():12-17. PubMed ID: 35580405
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of estrogen-progestogen therapy for women with vascular retained products of conception following miscarriage or abortion.
Yamaguchi M; Nishimura A; Motohara T; Ohba T; Kondoh E
Taiwan J Obstet Gynecol; 2023 Sep; 62(5):661-666. PubMed ID: 37678992
[TBL] [Abstract][Full Text] [Related]
16. Pregnancies Following Hysteroscopic Removal of Retained Products of Conception after Delivery Versus Abortion.
Ganer Herman H; Kogan Z; Tairy D; Ben Zvi M; Kerner R; Ginath S; Bar J; Sagiv R
Gynecol Obstet Invest; 2018; 83(6):586-592. PubMed ID: 29945122
[TBL] [Abstract][Full Text] [Related]
17. Infertility Following Retained Products of Conception: Does the Timing of Surgical Intervention Matter?
Melcer Y; Smorgick N; Schneider D; Pansky M; Halperin R; Ben-Ami I
Isr Med Assoc J; 2016 Oct; 18(10):605-608. PubMed ID: 28471620
[TBL] [Abstract][Full Text] [Related]
18. Retained products of conception: What is the risk for recurrence on subsequent pregnancies?
Smorgick N; Mittler A; Ben-Ami I; Maymon R; Vaknin Z; Pansky M
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():1-5. PubMed ID: 29525517
[TBL] [Abstract][Full Text] [Related]
19. Two-step hysteroscopy for management of morbidly adherent retained products of conception.
Smorgick N; Rabinovitch I; Levinsohn-Tavor O; Maymon R; Vaknin Z; Pansky M
Arch Gynecol Obstet; 2019 Sep; 300(3):669-674. PubMed ID: 31321494
[TBL] [Abstract][Full Text] [Related]
20. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
